top of page
CRYSTALS revised.tif

Welcome to Zilberman's Lab

Prof. Meital Zilberman
Department of Biomedical Engineering

Tel Aviv University

About Prof. Meital Zilberman

Meital's picture.png

Prof. Zilberman holds an appointment of Professor with tenure at the Department of Biomedical Engineering and the Department of Materials Science and Engineering of Tel Aviv University. Her research interests are polymeric biomaterials, active implants and scaffolds for tissue engineering, and drug- delivery systems. During 2015-2020 she served as the president of Israel Society for Medical and Biological Engineering (ISMBE).

About Prof. Zilberman's Group

Combining polymer science, drug delivery, and tissue engineering aspects for creating novel active implants and scaffolds

In our research group we develop new polymeric systems, that combine tissue support or regeneration, with local release of drugs and therapeutic agents to the surrounding tissue. Functional filers are incorporated as well, to create unique composite structures with great medical relevance. The resulting active implants are studied for their mechanical, physical and biological properties.

In our recent studies hydrogels are selected due to their similarity to the extracellular matrix. When developing functional substitutes for damaged or diseased tissues, the use of natural polymers is advantageous due to their biocompatibility, biodegradability, promotion of cell proliferation, and resemblance to the extracellular matrix. Thorough understanding of the formulation - structure - properties - function effects in these systems is aimed to provide new solutions to basic unmet needs in the medical field, that are channeled to be used in life-saving applications, enhance man's welfare and prolong human life.

Hemostatic Biodhesives and Medical Sealants

Novel biadhesives based on the natural polymers gelatin and alginate, and crosslinked by carbodiimide enable high strength, excellent sealing ability and biocompatibility and cell migration. Unique composite formulations are achieved by incorporating hemostatic agents, fibers and hydroxyapatite. 

bottom of page